The Monitoring Gap Nobody Talks About
The traditional blood glucose meter has been the backbone of diabetes care for decades. A small drop of blood on a test strip, a number in seven seconds, done. Meters themselves are inexpensive — most retail between $15 and $30 at national pharmacy chains — but the real cost lives in the strips. Industry reports show people testing three to four times daily spend a meaningful portion of their monthly budget on strips alone, and many patients ration their testing to stretch supplies.
That rationing creates a blind spot. A single fasting reading at 7 a.m. tells you very little about how your body responded to lunch, the afternoon snack, or that evening walk. Blood sugar moves constantly, and the traditional approach gives you snapshots rather than a story.
The other quiet problem is avoidance. Plenty of people with prediabetes or early type 2 diabetes simply do not want to prick their fingers several times a day. They know monitoring would help, but the friction wins. This is precisely where continuous glucose monitors (CGMs) changed the conversation in the United States.
How the CGM Wave Changed Monitoring
A CGM uses a tiny sensor worn on the upper arm that measures glucose in the interstitial fluid continuously, sending readings to a smartphone app. You can see your number any time, watch trend arrows, and spot patterns without a single fingerstick.
Prescription CGMs like the Dexcom G7 and Abbott FreeStyle Libre 3 Plus dominate the market. The Dexcom G7 offers the fastest warm-up time, readings every five minutes, and the strongest alert system — including a predictive low alert that can warn of a hypo about 20 minutes before it hits. Many insured patients pay $0 at the pharmacy, though the list price without coverage runs roughly $350 to $400 per month. The FreeStyle Libre 3 Plus lasts 15 days per sensor, reads every minute, and runs about $160 per month without insurance, making it the value leader among prescription options.
Then came the over-the-counter revolution. The Dexcom Stelo and Abbott Libre Rio are now sold without a prescription at major retailers, designed specifically for people with type 2 diabetes not on insulin, prediabetes, or general metabolic curiosity. Stelo runs about $99 per month, and Libre Rio sits around $89 to $99. No doctor visit required. You order online or grab it at the pharmacy counter.
That shift matters. For the first time, millions of Americans who were never considered "sick enough" for a prescription CGM can access real-time glucose data and actually see what their breakfast cereal does to their blood sugar.
Matching the Monitor to Your Situation
| Device | Type | Approximate Monthly Cost | Best For | Strengths | Trade-offs |
|---|
| Traditional meter (e.g., Contour Next, OneTouch) | Fingerstick | $15–30 for meter; strips vary | People testing occasionally or needing spot checks | Low upfront cost, widely available, no prescription | Only snapshots, ongoing strip expense, easy to skip |
| Dexcom G7 | Prescription CGM | $0 with many plans; ~$350–400 without | Type 1, insulin users, people needing hypo alerts | Fastest warm-up, predictive low alert, pump integration, best-in-class accuracy | Priciest without coverage, 10.5-day wear |
| FreeStyle Libre 3 Plus | Prescription CGM | ~$160 without insurance | Type 2 on insulin, value seekers | 15-day wear, readings every minute, connects to all major pump brands | 60-minute warm-up, fewer alert options than Dexcom |
| Dexcom Stelo | OTC CGM | ~$99 | Prediabetes, non-insulin type 2, metabolic tracking | No prescription, 15-day wear, simple app | No hypo alarm, not for people at risk of dangerous lows |
| Abbott Libre Rio | OTC CGM | ~$89–99 | Budget-focused prediabetes and type 2 users | Most affordable CGM option, familiar LibreLink app | Newer product with thinner review history |
Real People, Real Adjustments
Take Sarah, a 52-year-old administrative assistant from Austin who was diagnosed with type 2 diabetes last spring. Her doctor suggested a traditional meter, but Sarah admitted she tested twice a day at most — mornings and whenever she remembered. "I was flying blind after lunch," she says. Her doctor then prescribed the FreeStyle Libre 3 Plus. Within two weeks, Sarah noticed her blood sugar spiked every afternoon around 2 p.m. She traced it to the iced latte and granola bar she grabbed on the way back from meetings. She swapped the granola bar for a handful of almonds and cut the flavored syrup, and her afternoon numbers flattened out.
Mark, a retired school bus driver in Phoenix in his late sixties, went the over-the-counter route. He has prediabetes and wanted to avoid sliding into a full diabetes diagnosis. He bought the Dexcom Stelo without a prescription and used it for a month to map how his body responded to his usual meals. "I found out white rice was my biggest problem," he says. "My wife and I eat a lot of Mexican food, so now I order extra beans and skip the rice. My glucose stays much steadier."
Making It Work with Medicare and Insurance
If you are 65 or older and on Medicare, the picture is different. Medicare covers CGMs for people who take insulin or have a documented history of serious low blood sugar episodes. Coverage falls under Part B durable medical equipment: you pay the annual deductible, then 20% coinsurance on the Medicare-approved amount for both the device and ongoing supplies. Many Medicare Advantage plans bring that down to $0 at the pharmacy.
The caveat: if your type 2 diabetes is managed with oral medication alone and you have no history of dangerous lows, you may not meet Medicare's eligibility bar yet. That is worth a frank conversation with your doctor, who can document which route you qualify under.
For those with commercial insurance, manufacturers run savings programs that can bring out-of-pocket costs down considerably. Dexcom's savings center and Abbott's cost and coverage pages are worth checking before you pay list price. Both companies also offer assistance programs for uninsured or underinsured patients.
A Practical Action Plan
- Start with your doctor. Ask whether a prescription CGM makes sense for your situation, and whether your insurance covers it. Bring up the Medicare eligibility question if it applies to you.
- If you have type 2 diabetes not on insulin or prediabetes, consider a trial month with an OTC option like Stelo or Libre Rio. One month of data will show you patterns you cannot get any other way.
- If you are insulin-dependent, prioritize a prescription CGM with strong alerts. Dexcom G7's predictive low warning can be a genuine safety net, especially overnight.
- Compare your pharmacy cost with manufacturer savings programs before committing. What your insurance quotes and what you actually pay can differ substantially.
- Think about what you will do with the data. A CGM only helps if you act on it — logging meals, adjusting portions, and reviewing weekly trends with your care team.
Blood sugar monitoring has moved past the fingerstick era. The right device for you depends on your diagnosis, your insulin use, your budget, and how much data you actually want. Start with one conversation with your doctor, one honest look at your daily routine, and choose the tool that removes friction rather than adding it. That is the whole game — making monitoring so easy that you actually do it.
研究の知恵